Technology enables inference of subjective outcomes from routinely collected data...
Vial, a leading global contract research organization (CRO) providing next-generation clinical trial management services, announced the enrollment of the first patient in the pivotal clinical trial, "COOL-3s", evaluating the OcuCool system, developed by RecensMedical, Inc. ("RecensMedical"), a distinguished medical device company based in South Korea. ...
Transforming Heart Failure Management: Astellas, Eko Health & Welldoc Collaborate...
Surgeons in the Division of Thoracic Surgery at JFK University Medical Center first in the State of New Jersey to perform this surgery...
Marks a departure from traditional liquid reagent-based testing methods...
Pacifica Salud Hospital has joined the Global Provider Network (GPN), ushering in a new era of streamlined and easy access for American consumers and self-funded employers to access one of Latin America's top healthcare providers....
Devyser's novel test for detecting donor-derived cell-free DNA in blood samples from kidney-transplant patients and its product for screening and follow-up of stem cell transplanted patients fulfill IVDR requirements in Europe. These tests are the first post-transplant monitoring NGS products to be approved under the new, more comprehensive regulation that came into force in May 2022 and confirm Devyser's two NGS products meet the established safety, efficacy, and quality requirements....
Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments....
UK-based The Rodnight Partnership ties up with India's Pluss...
Affirms Strong Performance and Focus on India Amidst Ongoing Expansion...
